Svb Wealth LLC Horizon Therapeutics Public LTD CO Transaction History

Svb Wealth LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$62.39 - $113.8 $19,590 - $35,733	314 Added 9.45%	3,635 $413,000
Q3 2022 Nov 09, 2022	BUY	$58.92 - $84.67 $195,673 - $281,189	3,321 New	3,321 $206,000
Q2 2022 Aug 16, 2022	SELL	$79.4 - $116.36 $164,596 - $241,214	-2,073 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$86.42 - $109.81 $2,592 - $3,294	30 Added 1.47%	2,073 $218,000
Q4 2021 Feb 15, 2022	SELL	$98.56 - $119.91 $29,568 - $35,973	-300 Reduced 12.8%	2,043 $220,000
Q3 2021 Nov 09, 2021	SELL	$91.91 - $110.37 $4,779 - $5,739	-52 Reduced 2.17%	2,343 $257,000
Q2 2021 Aug 13, 2021	BUY	$86.24 - $95.92 $206,544 - $229,728	2,395 New	2,395 $224,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Svb Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Svb Wealth LLC with notifications on news.